Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-based design of stapled peptides targeting the oligomeric state of lactate dehydrogenase.

European journal of medicinal chemistry·2026
Same author

Imidazole-Based AT<sub>1</sub> Receptor Ligands: Design, Synthesis and Pharmacological Evaluation.

Molecules (Basel, Switzerland)·2026
Same author

Citrate-functionalised hydroxyapatite mimics the microenvironment of bone metastases and demonstrates the role of citrate in prostate cancer colonization of bone.

Acta biomaterialia·2026
Same author

Hetero-oligomerization drives structural plasticity of eukaryotic peroxiredoxins.

Nature chemical biology·2026
Same author

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity.

Molecular oncology·2026
Same author

Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC.

Science signaling·2026

Related Experiment Video

Updated: Dec 25, 2025

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay
09:18

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay

Published on: October 20, 2018

7.8K

Interrogating the Lactate Dehydrogenase Tetramerization Site Using (Stapled) Peptides.

Léopold Thabault1,2, Lucie Brisson2,3, Chiara Brustenga1

  • 1Louvain Drug Research Institute (LDRI), Université Catholique de Louvain (UCLouvain), B-1200 Brussels, Belgium.

Journal of Medicinal Chemistry
|April 7, 2020
PubMed
Summary

Researchers developed novel peptides to disrupt lactate dehydrogenase (LDH) tetramerization, offering a new strategy for cancer therapy by targeting enzyme structure rather than active sites.

More Related Videos

Specificity Analysis of Protein Lysine Methyltransferases Using SPOT Peptide Arrays
08:48

Specificity Analysis of Protein Lysine Methyltransferases Using SPOT Peptide Arrays

Published on: November 29, 2014

14.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K

Related Experiment Videos

Last Updated: Dec 25, 2025

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay
09:18

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay

Published on: October 20, 2018

7.8K
Specificity Analysis of Protein Lysine Methyltransferases Using SPOT Peptide Arrays
08:48

Specificity Analysis of Protein Lysine Methyltransferases Using SPOT Peptide Arrays

Published on: November 29, 2014

14.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K

Area of Science:

  • Biochemistry
  • Enzymology
  • Cancer Biology

Background:

  • Lactate dehydrogenases (LDHs) are crucial in cancer metabolism.
  • Their catalytic sites are difficult to target for cancer therapy.
  • Targeting enzyme oligomerization presents a novel therapeutic approach.

Purpose of the Study:

  • To investigate disrupting lactate dehydrogenase (LDH) tetramerization.
  • To develop novel inhibitors targeting LDH tetramerization sites.
  • To explore a new molecular mechanism for LDH inhibition.

Main Methods:

  • Designed a dimeric protein model of LDH-H.
  • Utilized WaterLOGSY nuclear magnetic resonance and microscale thermophoresis.
  • Identified and characterized α-helical peptides and stapled derivatives targeting tetramerization sites.

Main Results:

  • Developed a macrocyclic peptide that competes with LDH tetramerization domains.
  • Successfully disrupted and destabilized LDH tetramers.
  • Validated peptides and macrocycles as tools for designing LDH tetramerization disruptors.

Conclusions:

  • Disrupting LDH oligomerization is an achievable strategy.
  • Targeting tetramerization sites offers a novel mechanism for LDH inhibition.
  • Developed pharmacological tools for future drug discovery in cancer therapy.